Want to see SG:A50 full AI Analyst Report?
A50 Stock Chart & Stats
S$0.06
S$0.00(0.00%)
At close: 4:00 PM EST
S$0.06
S$0.00(0.00%)
Day’s Range― - ―
52-Week RangeS$0.04 - S$0.07
Previous CloseN/A
Volume460.80K
Average Volume (3M)2.14M
Market Cap
S$1.40B
Enterprise ValueS$2.45B
Total Cash (Recent Filing)S$124.21M
Total Debt (Recent Filing)S$1.12B
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Aug 31, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding26,443,615,000
10 Day Avg. Volume2,062,170
30 Day Avg. Volume2,143,033
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)2.41
Price to Sales (P/S)2.88
P/FCF Ratio33.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)S$455.90M
Bulls Say, Bears Say
Bulls Say
High Gross MarginA 74.83% gross margin indicates durable service-level pricing power and low variable cost per procedure. For a specialist hospital group this supports absorption of fixed costs, funds reinvestment in clinical capabilities, and resilience to modest volume swings over the next 2–6 months.
Specialized Women's & Children's Care FocusA concentrated offering in maternity, fertility and paediatrics creates a steady, less cyclical demand base, referral networks, and cross-sell opportunities for diagnostics and packages. This specialization underpins stable patient flows and pricing leverage over a multi-month horizon.
Some FCF Conversion CapabilityConverting over half of accounting losses into free cash flow shows underlying operational cash generation capacity. If revenue stabilizes, this conversion ability can help service obligations and fund incremental investments without immediate capital raises, improving resilience.
Bears Say
Negative Net ProfitabilityA negative net margin signals the business is not currently profitable after operating and financing costs. This reduces retained earnings and the ability to self-fund growth or absorb shocks, and indicates structural issues in pricing, mix, or cost control that must be fixed to restore sustainable returns.
High LeverageA D/E of 2.38 denotes elevated leverage for a healthcare operator, increasing interest expense and refinancing risk. High financial leverage constrains strategic flexibility, makes capital expenditure and M&A harder, and raises vulnerability to volume or margin shocks over the medium term.
Severe Decline In Free Cash Flow GrowthA dramatic fall in FCF growth, coupled with low operating cash flow to net income (0.22), means earnings are not translating into cash. This heightens short-term liquidity and solvency risk, limiting capacity to invest or reduce debt without external funding or operational fixes.
Thomson Medical Group Ltd. News
A50 FAQ
What was Thomson Medical Group Ltd.’s price range in the past 12 months?
Thomson Medical Group Ltd. lowest share price was S$0.04 and its highest was S$0.07 in the past 12 months.
What is Thomson Medical Group Ltd.’s market cap?
Thomson Medical Group Ltd.’s market cap is S$1.40B.
When is Thomson Medical Group Ltd.’s upcoming earnings report date?
Thomson Medical Group Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 60 days.
How were Thomson Medical Group Ltd.’s earnings last quarter?
Thomson Medical Group Ltd. released its earnings results on Feb 11, 2026. The company reported S$0 earnings per share for the quarter, the consensus estimate of N/A by S$0.
Is Thomson Medical Group Ltd. overvalued?
According to Wall Street analysts Thomson Medical Group Ltd.’s price is currently Overvalued.
Does Thomson Medical Group Ltd. pay dividends?
Thomson Medical Group Ltd. pays a N/A dividend of <S$0.001 which represents an annual dividend yield of N/A. See more information on Thomson Medical Group Ltd. dividends here
What is Thomson Medical Group Ltd.’s EPS estimate?
Thomson Medical Group Ltd.’s EPS estimate is 0.
How many shares outstanding does Thomson Medical Group Ltd. have?
Thomson Medical Group Ltd. has 26,443,615,000 shares outstanding.
What happened to Thomson Medical Group Ltd.’s price movement after its last earnings report?
Thomson Medical Group Ltd. reported an EPS of S$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 1.639%.
Which hedge fund is a major shareholder of Thomson Medical Group Ltd.?
Currently, no hedge funds are holding shares in SG:A50
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Thomson Medical Group Ltd.
Operating as an investment holding company, Thomson Medical Group Limited delivers healthcare services specifically tailored for women and children across Singapore, Malaysia, and Vietnam. Its core assets include the Thomson Medical Centre, alongside an extensive network of affiliated medical clinics and healthcare facilities. The group's service portfolio encompasses immediate care solutions, covering basic resuscitation, ECG, vaccinations, intravenous fluid and antibiotic treatments, minor surgeries and procedures, wound management, and essential diagnostic imaging like X-rays and laboratory tests. Additionally, it provides comprehensive health screening, aesthetic and dermatological services, pain and rehabilitation management, and traditional herbal tea offerings. Furthermore, Thomson Medical Group specializes in a broad spectrum of medical areas. These include women's and children's health, fertility and family planning, ophthalmology, general surgery, urology, preventive health, healthy aging, advanced diagnostic imaging, breast care, cardiology, respiratory and critical care, endocrinology, dermatology, day surgery, general surgical care, counselling, therapy, Traditional Chinese Medicine (TCM), and specialized care for bone, joint, gynecological oncology, dental, and spine conditions. The company's diverse range of products and services are marketed under well-known brands such as Thomson Women's Clinic, Thomson Fertility Centre, Thomson Paediatric Clinic, Thomson Specialists, Thomson Chinese Medicine, Thomson Surgical Centre, Thomson Dental Centre, Thomson Hospital Kota Damansara, TMC Fertility, TMC Care Pharmacy, FV Hospital, and FV Saigon Clinic. Established in 1979, Thomson Medical Group Limited is headquartered in Singapore.
Technical Analysis
Cordlife Group
―
Raffles Medical Group
―
Asiamedic Limited
―
OUE Lippo Healthcare Limited
―
Bangkok Dusit Medical Services Public Co Ltd Shs UnSp Singapore Depositary Receipt Repr 2/1 Sh
―
Options Prices
Currently, No data available
---